1. Home
  2. DYN vs CAMT Comparison

DYN vs CAMT Comparison

Compare DYN & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • CAMT
  • Stock Information
  • Founded
  • DYN 1984
  • CAMT 1987
  • Country
  • DYN United States
  • CAMT Israel
  • Employees
  • DYN N/A
  • CAMT N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • CAMT Electronic Components
  • Sector
  • DYN Health Care
  • CAMT Technology
  • Exchange
  • DYN Nasdaq
  • CAMT Nasdaq
  • Market Cap
  • DYN 3.4B
  • CAMT 3.7B
  • IPO Year
  • DYN 2020
  • CAMT 2000
  • Fundamental
  • Price
  • DYN $28.39
  • CAMT $74.07
  • Analyst Decision
  • DYN Strong Buy
  • CAMT Strong Buy
  • Analyst Count
  • DYN 9
  • CAMT 6
  • Target Price
  • DYN $52.44
  • CAMT $111.50
  • AVG Volume (30 Days)
  • DYN 1.0M
  • CAMT 539.9K
  • Earning Date
  • DYN 11-12-2024
  • CAMT 11-12-2024
  • Dividend Yield
  • DYN N/A
  • CAMT 1.80%
  • EPS Growth
  • DYN N/A
  • CAMT 30.62
  • EPS
  • DYN N/A
  • CAMT 2.18
  • Revenue
  • DYN N/A
  • CAMT $400,631,000.00
  • Revenue This Year
  • DYN N/A
  • CAMT $36.26
  • Revenue Next Year
  • DYN N/A
  • CAMT $16.18
  • P/E Ratio
  • DYN N/A
  • CAMT $33.96
  • Revenue Growth
  • DYN N/A
  • CAMT 29.71
  • 52 Week Low
  • DYN $9.82
  • CAMT $59.33
  • 52 Week High
  • DYN $47.45
  • CAMT $140.50
  • Technical
  • Relative Strength Index (RSI)
  • DYN 42.04
  • CAMT 41.99
  • Support Level
  • DYN $27.99
  • CAMT $78.58
  • Resistance Level
  • DYN $35.68
  • CAMT $89.94
  • Average True Range (ATR)
  • DYN 2.09
  • CAMT 4.43
  • MACD
  • DYN 0.23
  • CAMT -0.12
  • Stochastic Oscillator
  • DYN 9.12
  • CAMT 10.49

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About CAMT Camtek Ltd.

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

Share on Social Networks: